haloperidol has been researched along with ne 100 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Fiechtner, B; Glossmann, H; Hoffmann, RD; Laggner, C; Langer, T; Moebius, FF; Poles, G; Schieferer, C | 1 |
| Mamolo, MG; Menegazzi, R; Romano, M; Zampieri, D | 1 |
| Börgel, F; Catapano, CV; Civenni, G; Friedland, K; Holtschulte, C; Humpf, HU; Kopp, N; Laurini, E; Lehmkuhl, K; Pricl, S; Schepmann, D; Wünsch, B | 1 |
3 other study(ies) available for haloperidol and ne 100
| Article | Year |
|---|---|
Discovery of high-affinity ligands of sigma1 receptor, ERG2, and emopamil binding protein by pharmacophore modeling and virtual screening.
Topics: Animals; Carrier Proteins; Databases, Factual; Guinea Pigs; Humans; Hydrogen Bonding; Hydrophobic and Hydrophilic Interactions; Isomerism; Ligands; Models, Molecular; Quantitative Structure-Activity Relationship; Radioligand Assay; Receptors, sigma; Saccharomyces cerevisiae; Sigma-1 Receptor; Steroid Isomerases | 2005 |
New piperidine-based derivatives as sigma receptor ligands. Synthesis and pharmacological evaluation.
Topics: Cell Line, Tumor; Humans; Ligands; Piperidines; Receptors, sigma | 2018 |
Novel σ
Topics: Amination; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cyclohexanes; Humans; Male; Mice; Prostatic Neoplasms; Receptors, sigma; Sigma-1 Receptor; Structure-Activity Relationship | 2021 |